4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-011692
CHIEF COMMERCIAL OFFICER sold 87,269 shares at an average $25.96 ($2,265,339)
- CHIEF COMMERCIAL OFFICER acquired 87,269 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-29 | Option exercise 10b5-1 | +15,000 | $15.52 | $232,800 | 24,415 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-29 | Option exercise 10b5-1 | +20,000 | $15.50 | $310,000 | 44,415 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-29 | Option exercise 10b5-1 | +6,296 | $12.97 | $81,659 | 50,711 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-29 | Option exercise 10b5-1 | +7,432 | $11.97 | $88,961 | 58,143 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-29 | Option exercise 10b5-1 | +15,307 | $10.76 | $164,703 | 73,450 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-29 | Sale 10b5-1 | −64,035 | $25.21 | $1,614,322 | 9,415 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-05-01 | Option exercise 10b5-1 | +13,406 | $13.35 | $178,970 | 22,821 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-05-01 | Option exercise 10b5-1 | +8,671 | $11.10 | $96,248 | 31,492 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-05-01 | Option exercise 10b5-1 | +1,157 | $17.76 | $20,548 | 32,649 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-05-01 | Sale 10b5-1 | −23,234 | $28.02 | $651,017 | 9,415 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-29 | Option exercise · Share Option 10b5-1 | −15,000 | 0 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-29 | Option exercise · Share Option 10b5-1 | −20,000 | 0 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-29 | Option exercise · Share Option 10b5-1 | −6,296 | 1,658 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-29 | Option exercise · Share Option 10b5-1 | −7,432 | 27,252 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-04-29 | Option exercise · Share Option 10b5-1 | −15,307 | 23,361 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-05-01 | Option exercise · Share Option 10b5-1 | −13,406 | 27,594 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-05-01 | Option exercise · Share Option 10b5-1 | −8,671 | 21,059 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-05-01 | Option exercise · Share Option 10b5-1 | −1,157 | 37,511 | D | ||
| Open-market sales · 87,269 sh · avg $25.96 · $2,265,339 | |||||||
Loading xslF345X05/form4-05012025_100513.xml…